Thanks to his trusty Dexcom continuous glucose monitor (CGM), former boy band star Lance Bass is saying “bye bye bye” to ...

DexCom is all geared up to announce its second-quarter earnings towards the end of this month, and analysts anticipate a single-digit bottom-line growth.

Can DexCom still be a millionaire maker? Additionally, DexCom isn't a small company anymore. The stock's market cap is almost $27 billion even after falling 50%.

DexCom DXCM -0.78% and Abbott Diabetes Care entered a settlement and patent cross-license agreement, resolving all outstanding litigation between the companies. The companies have been involved in ...

Shares of DexCom Inc. tumbled more than 40% on Friday and were headed for their worst percentage drop on record, a day after the maker of diabetes-management equipment shocked investors with a cut ...

DexCom generates nearly $4 billion in annual sales on a user base of just 2.5 million to 2.6 million patients worldwide, a tiny fraction of those with diabetes.

SAN DIEGO-- (BUSINESS WIRE)-- DexCom, Inc. (NASDAQ:DXCM), the global leader in glucose biosensing, announced today it has launched a proprietary Generative AI (GenAI) platform, making Dexcom the ...

Dexcom launched its first over-the-counter continuous glucose monitor called Stelo on Monday. Users can buy a one-month supply online for $99, or sign up for an ongoing subscription at $89 a month.

Medical device maker Dexcom beat fourth-quarter sales estimates helped by resilient demand for its continuous glucose monitors (CGMs) used by patients with diabetes.

Medical device maker Dexcom beat Wall Street estimates for third-quarter revenue and profit on Thursday, helped by resilient demand for its continuous glucose monitors for diabetes patients and ...